CDC warns about drug-resistant stomach bug deemed "serious public health threat"
Doctors have limited options to treat the "extensively drug-resistant" strains of Shigella bacteria.
www.cbsnews.comHere’s a concise update on Shigella infections based on the latest publicly available reporting.
-
Most recent summaries show rising attention to extensively drug-resistant Shigella (XDR Shigella) in the United States, with public health agencies highlighting that a subset of infections are resistant to multiple commonly used antibiotics and may require alternative management and strict infection control measures. This trend has been echoed by major outlets reporting on CDC briefings and national surveillance updates in 2023 and 2026, underscoring the need for susceptibility testing and diligent reporting to prevent spread. [sources vary, with CDC updates and major news outlets covering the topic]
-
Health authorities emphasize that while Shigella typically causes gastroenteritis with diarrhea, fever, and abdominal cramps, the resistant strains complicate treatment, and there is concern about transmission through person-to-person contact, food, water, and surfaces. Providers are advised to follow local surveillance data, perform stool testing with antibiotic susceptibility when indicated, and report cases to public health authorities. [sources vary, with CDC and public health summaries]
-
Public health messaging continues to stress prevention: hand hygiene, safe food handling, thorough cleaning of surfaces, and isolation of symptomatic individuals to limit spread, particularly in settings with vulnerable populations or close contact.
Illustrative note:
- The discussion around XDR Shigella is part of broader antimicrobial resistance monitoring. A front-line antibiotic that once worked may be ineffective for some strains, so clinicians rely on lab susceptibility results to guide therapy and infection-control decisions. This has been a recurring theme in recent reporting from health agencies and major outlets. [sources vary]
If you’d like, I can pull the latest, country-specific briefings (e.g., UK, US, Canada) and summarize them with direct citations, or provide a brief one-page briefing for healthcare settings in London.